Omada Health, Inc. Amortization of Deferred Sales Commissions
Omada Health, Inc. (OMDA) reported Amortization of Deferred Sales Commissions of $1.93 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfDeferredSalesCommissions · last filed 2026-08-07
- Omada Health, Inc. amortization of deferred sales commissions for the quarter ending 2026-06-30 was $968.00K, a 17.05% increase year-over-year.
- Omada Health, Inc. amortization of deferred sales commissions for the quarter ending 2026-03-31 was $958.00K, a 30.52% increase year-over-year.
- Omada Health, Inc. amortization of deferred sales commissions for the quarter ending 2025-12-31 was $872.00K, a 17.52% increase year-over-year.
- Omada Health, Inc. amortization of deferred sales commissions for the quarter ending 2025-09-30 was $906.00K, a 30.74% increase year-over-year.
- Omada Health, Inc. amortization of deferred sales commissions for fiscal 2025 was $3.34M, a 26.33% increase from fiscal 2024.
- Omada Health, Inc. amortization of deferred sales commissions for fiscal 2024 was $2.64M, a 46.91% increase from fiscal 2023.
- Omada Health, Inc. amortization of deferred sales commissions for fiscal 2023 was $1.80M.
| Period end | Amortization of Deferred Sales Commissions 3 month | Amortization of Deferred Sales Commissions 6 month | Amortization of Deferred Sales Commissions 9 month | Amortization of Deferred Sales Commissions 12 month |
|---|---|---|---|---|
| 2026-06-30 | $968.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $1.93M 10-Q · filed 2026-08-07 | $2.80M derived: sum of 3 quarters · filed 2026-08-07 | $3.70M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $958.00K 10-Q · filed 2026-05-08 | $1.83M derived: sum of 2 quarters · filed 2026-05-08 | $2.74M derived: sum of 3 quarters · filed 2026-05-08 | $3.56M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $872.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $1.78M derived: sum of 2 quarters · filed 2026-03-06 | $2.60M derived: sum of 3 quarters · filed 2026-08-07 | $3.34M 10-K · filed 2026-03-06 |
| 2025-09-30 | $906.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $1.73M derived: sum of 2 quarters · filed 2026-08-07 | $2.47M 10-Q · filed 2025-11-07 | $3.21M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $827.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $1.56M 10-Q · filed 2026-08-07 | $2.30M derived: sum of 3 quarters · filed 2026-08-07 | $3.00M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $734.00K 10-Q · filed 2026-05-08 | $1.48M derived: sum of 2 quarters · filed 2026-05-08 | $2.17M derived: sum of 3 quarters · filed 2026-05-08 | |
| 2024-12-31 | $742.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $1.44M derived: sum of 2 quarters · filed 2026-03-06 | $2.64M 10-K · filed 2026-03-06 | |
| 2024-09-30 | $693.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $1.90M 10-Q · filed 2025-11-07 | ||
| 2024-06-30 | $1.21M 10-Q · filed 2025-08-08 | |||
| 2023-12-31 | $1.80M 10-K · filed 2026-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |